AVXL
Price
$1.50
Change
+$0.02 (+1.35%)
Updated
Oct 14, 04:59 PM (EDT)
Capitalization
217.84M
47 days until earnings call
Intraday BUY SELL Signals
MAZE
Price
$26.21
Change
-$0.45 (-1.69%)
Updated
Oct 14, 04:59 PM (EDT)
Capitalization
1.49B
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVXL vs MAZE

AVXL vs MAZE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AVXL vs. MAZE commentary
Oct 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and MAZE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AVXL with price predictions
Oct 13, 2026

AVXL's Indicator enters downward trend

The Aroon Indicator for AVXL entered a downward trend on October 13, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 278 similar instances where the Aroon Indicator formed such a pattern. In 240 of the 278 cases the stock moved lower. This puts the odds of a downward move at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for AVXL crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVXL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVXL advanced for three days, in 204 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

AVXL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.937) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. AVXL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVXL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for MAZE with price predictions
Oct 13, 2026

MAZE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for MAZE turned positive on September 22, 2026. Looking at past instances where MAZE's MACD turned positive, the stock continued to rise in 10 of 11 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MAZE's RSI Indicator exited the oversold zone, 4 of 5 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

Following a +7.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where MAZE advanced for three days, in 89 of 101 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 14 of 19 cases where MAZE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.

The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MAZE as a result. In 26 of 32 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

MAZE moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MAZE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

MAZE broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MAZE entered a downward trend on September 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. MAZE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.292) is normal, around the industry mean (26.782). MAZE has a moderately high P/E Ratio (191.339) as compared to the industry average of (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (63.291) is also within normal values, averaging (437.542).

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MAZE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
AVXL: Fundamental Ratings
AVXL
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVXLMAZE
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 27 days ago
79%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
COMPARISON
Comparison
Oct 14, 2026
Stock price -- (AVXL: $1.48 vs. MAZE: $26.66)
Brand notoriety: AVXL and MAZE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 131% vs. MAZE: 89%
Market capitalization -- AVXL: $217.84M vs. MAZE: $1.49B
AVXL [@Biotechnology] is valued at $217.84M. MAZE’s [@Biotechnology] market capitalization is $1.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 1 FA rating(s) are green while MAZE’s FA Score has 1 green FA rating(s).

  • AVXL’s FA Score: 1 green, 4 red.
  • MAZE’s FA Score: 1 green, 4 red.
According to our system of comparison, MAZE is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 4 TA indicator(s) are bullish while MAZE’s TA Score has 3 bullish TA indicator(s).

  • AVXL’s TA Score: 4 bullish, 3 bearish.
  • MAZE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than MAZE.

Price Growth

AVXL (@Biotechnology) experienced а -7.50% price change this week, while MAZE (@Biotechnology) price change was +0.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.35%. For the same industry, the average monthly price growth was -18.86%, and the average quarterly price growth was -19.74%.

Reported Earning Dates

AVXL is expected to report earnings on Nov 30, 2026.

MAZE is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-8.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
AVXL
Daily Signal:
Gain/Loss:
MAZE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USNA15.460.51
+3.41%
USANA Health Sciences
SYM40.890.11
+0.27%
Symbotic
TK15.46-0.10
-0.64%
Teekay Corporation Ltd
AMT179.43-3.13
-1.71%
American Tower Corp
CNTX0.28-0.03
-9.84%
Context Therapeutics

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with TENX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
-1.99%
TENX - AVXL
47%
Loosely correlated
-12.57%
MAZE - AVXL
45%
Loosely correlated
-3.75%
AXON - AVXL
45%
Loosely correlated
-0.26%
VCYT - AVXL
41%
Loosely correlated
-2.07%
ARRY - AVXL
41%
Loosely correlated
-0.83%
More

MAZE and

Correlation & Price change

A.I.dvisor indicates that over the last year, MAZE has been loosely correlated with AVXL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MAZE jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAZE
1D Price
Change %
MAZE100%
-3.75%
AVXL - MAZE
45%
Loosely correlated
-1.99%
VKTX - MAZE
41%
Loosely correlated
-5.96%
IMNM - MAZE
37%
Loosely correlated
-8.20%
ADMA - MAZE
35%
Loosely correlated
+1.28%
KYTX - MAZE
31%
Poorly correlated
-7.09%
More